There is a version of this comparison that finishes in one sentence. Both formats are food supplements, both sit under Great Britain food law rather than the medicines regime, and both can put the same quantity of the same vitamin into the same person. Everything after that is an argument about a verb.

The spray does not sell the nutrient. It sells the arrival of it, above all the speed — an unusual thing to sell here, because it sits outside the framework governing most supplement marketing.

What each format puts in front of a buyer

The claim that did not survive

On 17 June 2026 the Advertising Standards Authority upheld a complaint about a paid advertisement for BetterYou’s vitamin D3 and K2 daily oral spray, which ran in the January 2026 edition of Waitrose & Partners’ Food magazine. In large type, the ad said 95 per cent agreed the product delivered vitamin D quickly and efficiently, attributing that in smaller text to an independent consumer trial of 245 participants using it daily for six weeks. Elsewhere it described oral sprays as delivering fast, effective nutrition absorption.

The authority’s position was that such a claim needs objective evidence of fast, efficient delivery inside the body, not what users reported thinking after six weeks. It then worked through the five studies the company submitted. Work on pig tissue in a laboratory, not in human participants, did not carry across. The human trials ran to between 40 and 75 participants and tracked vitamin D status over weeks and months, which is no measure of how quickly anything is absorbed. One found spray and capsules equally effective.

The ruling is narrower than a headline makes it, and the narrow version is the useful one. It did not find that sprays fail to work; it accepted the studies showed them raising vitamin D levels. What the evidence did not establish was the speed being sold.

Why that argument happens outside the register

The Great Britain register, in the Department of Health and Social Care’s own description, sets out all authorised and rejected nutrition and health claims, and only those on it may be used here. It is a closed list, and holds no entry for getting there sooner: absorption speed is not a health claim, but an ordinary performance claim, judged against the CAP Code rules the ASA cited here, 3.1 on misleadingness and 3.7 on substantiation.

Hence the category’s odd shape: the nutrition half of a spray’s pitch is constrained by a public list, the delivery half only by a duty to hold evidence if challenged.

The strength question is the larger one

Set the absorption argument aside and a plainer problem remains. UK advice concerns 10 micrograms a day. The adult sprays listed run to 1000, 3000 and 4000 IU — 25, 75 and 100 micrograms. The largest lands precisely on the figure the NHS says not to exceed, leaving no headroom for a multivitamin or cod liver oil the same day. The 400 IU junior and infant sprays sit well inside the children’s limits.

None of this is unique to sprays; as we noted on the one standing UK recommendation, strength inflation is this category’s oldest habit. But a spray makes a large dose feel incidental in a way a tablet does not.

Where the spray earns its place

On practical grounds rather than pharmacological ones. Some people cannot swallow tablets, or will not. A spray needs no water and can be given to a small child without splitting anything. Adherence decides whether a supplement does anything at all, and a format used daily beats a cheaper one going stale in a drawer. The 3000 IU D3 and K2 spray was listed at £7.99 on the brand’s collection page as of this writing, though that is a promotion against a £11.49 list price.

It bears saying, since the aisle rarely does: both are regulated as food in Great Britain rather than as medicines, and neither is there to diagnose, treat, cure or prevent disease. Anyone pregnant, on prescribed medication, or dosing a child should ask a pharmacist.

Pros and cons

Verdict

Oral sprays are a legitimate way to take vitamin D and a real answer for people who struggle with tablets. They are not a demonstrated shortcut.

So the buying rule inverts the marketing. Decide the strength first, against the 10 microgram figure and whatever else in the cupboard contributes. Then choose the format on whether you will actually take it. The delivery claim, which does the persuading, has least behind it.